Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 29;46(3):213-218.
doi: 10.5152/tud.2019.19051. Print 2020 May.

Turkish Urologists' preferences regarding antibiotic prophylaxis for transrectal prostate biopsy

Abdullah Demirtaş  1 , Esma Eren  2 , Gökhan Sönmez  3 , Şevket Tolga Tombul  1 , Emine Alp  4 ; Turkish Urology Academy, Study Group of Prostate Biopsy  5
Affiliations

Turkish Urologists' preferences regarding antibiotic prophylaxis for transrectal prostate biopsy

Abdullah Demirtaş et al. Turk J Urol. .

Abstract

Objective: Antibiotic prophylaxis for transrectal prostate biopsy (PB) is very important in preventing infectious complications, and in this study, we aimed to evaluate the antibiotic preferences of Turkish urologist for transrectal PB.

Material and methods: The survey about PB and antibiotic prophylaxis behaviors was administered to urologists working in Turkey who had previously participated in at least one international and one national congress.

Results: A total of 237 urologists were included in the study. Antibiotic prophylaxis prior to PB was performed by 234 (98.7%) participants. Rectal swabbing prior to PB was not performed by 227 (95.8%) participants. The most common complication associated with PB was prostatitis (63%), followed by urinary tract infection (29%). Only 25.7% of Turkish urologists reported a single dose of antibiotic prophylaxis. Our participants often administered antibiotic prophylaxis for a period of 3, 5, or 7 days (16%, 21.1%, 35.9%, respectively). The most common antibiotic agent preferred for prophylaxis was ciprofloxacin (65%).

Conclusion: The biopsy behavior of Turkish urologists was mostly compatible with the literature, but it was revealed that Turkish urologists do not prefer single-dose antibiotic therapy, and their practice patterns regarding the administration of pre-biopsy rectal swabbing are inconsistent with the literature.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Hospital types of study groups
Figure 2
Figure 2
Number of median beds and biopsies per month according to the hospital types
Figure 3
Figure 3
Antibiotic agents preferred for prophylaxis based on the hospital type
None
See this image and copyright information in PMC

References

    1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet. 2015;385:977–1010. doi: 10.1016/S0140-6736(14)62038-9. - DOI - PMC - PubMed
    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi: 10.3322/caac.21262. - DOI - PubMed
    1. Roberts MJ, Scott S, Harris PN, Naber K, Wagenlehner FME, Doi SAR. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World J Urol. 2018;36:323–30. doi: 10.1007/s00345-017-2163-9. - DOI - PubMed
    1. Lundström KJ, Drevin L, Carlsson S, Garmo H, Loeb S, Stattin P, et al. Nationwide population-based study of infections after transrectal ultrasound guided prostate biopsy. J Urol. 2014;192:1116–22. doi: 10.1016/j.juro.2014.04.098. - DOI - PubMed
    1. Bruyere F, Malavaud S, Bertrand P, Decock A, Cariou G, Doublet JD, et al. Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy. J Urol. 2015;193:145–50. doi: 10.1016/j.juro.2014.07.086. - DOI - PubMed

LinkOut - more resources